Effects of β-Aescin on the expression of nuclear factor-κB and tumor necrosis factor-α after traumatic brain injury in rats

Journal of Zhejiang University: Science B

Volumn 6, Issue 1, 2005, Pages 28-32

  Xiao, Guo min ^a   Wei, Jing ^a  

^a Second Hospital of Hangzhou   (China)

Author keywords

Brain injuries; Nuclear factor B; R65; Tumor necrosis factor ; Aescin

Indexed keywords

ESCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BODY WATER; BRAIN EDEMA; BRAIN INJURY; COMPARATIVE STUDY; DRUG ANTAGONISM; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BODY WATER; BRAIN EDEMA; BRAIN INJURIES; ESCIN; NF-KAPPA B; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; THIOCARBAMATES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16644392647     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.2005.B0028     Document Type: Article

References (15)

1. Baeuerle, P., Baltimore, D., 1996. NF-Kappa B: Ten years after.Cell,87:13–20. DOI: 10.1016/S0092-8674(00)81318-5
2. Bakdwin, A.S. Jr, 1996. The NF-κB and IκB proteins: new discoveries and insights.Annu Rev Immunol,14:649–683. DOI: 10.1146/annurev.immunol.14.1.649
3. Beg, A.A., Bakdwin, A.S. Jr, 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors.GeneDev,9:427–433.
4. Beg, A.A., Ruben, S.M., Schcinman, R.I., Haskill, S., Rosen, C.A., Baldwin, A.S. Jr, 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention.Genes Dev,10:1899–1913. DOI: 10.1101/gad.6.10.1899
5. Connor, T.J., Song, C., Leonard, B.E., Anisman, H., Merali, Z, 1998. An assessment of the effects of central inter-leukin-1 beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural neurochemical, endocrine and immune paramenters in the rat.Neuroscience,84:923–933. DOI: 10.1016/S0306-4522(97)00533-2
6. Fransserr, C., Defraigne, J.O., Detry, O, 1995. Antioxidant defense and free radical production in a rabbit model of kidney ischemia-reperfusion.Transplant-Proc,27:2880–2883.
7. Hiai, S., Yokoyama, H., Oura, H, 1981. Effect of Aescin of adreno-corticotropin and corticosterone levels in rat plasma.Chen Pharm Bull,29:490. DOI: 10.1248/cpb.29.490
8. Ichikawa, K., DeGroot, L.J., Refetoff, S.H., Nuorwitz, A.L., Pollak, E.R, 1986. Nuclear thyroid hormone receptors in cultured human fibrobasts: improved method of isolation, partial characterization, and interaction with chromation.Metabolism,35:861–868. DOI: 10.1016/0026-0495(86)90229-5
9. Korner, M., Rattner, A., Mauxion, F., Sen, R., Citri, Y, 1989. A brain specific transcription activator.Neuron,3:563–572. DOI: 10.1016/0896-6273(89)90266-3
10. Lee, J.I., Burekart, G.J, 1988. Nuclear factor-kappa B: important transcription factor and therapeatic target.J Clin Pharmacol,38:981–993. DOI: 10.1177/009127009803801101
11. Lü, H.S, 1993. β-Aescin and appliation in clinic.J Tongji Medical University,22(3):218–220 (in Chinese).
12. Nanaka, M., Chen, X.H., Pierce, J.E., Leoni, M.J., Melntosk, T.K., Wolf, J.A., Smith, D.H, 1999. Prolonged activation of NF-κB following traumatic brain injury in rats.J Neurotrauma,16:1023–1034. DOI: 10.1089/neu.1999.16.1023
13. Stover, J.F., Schoning, B., Sakowitz, O.W., Woiciechowsky, C., Unterberg, A.W., 2001. Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis actor-alpha following controlled cortical impact injury in rats.J Neurosurg,94:782–787. DOI: 10.3171/jns.2001.94.5.0782
14. Sullivan, P.G., Bruce-Keller, A.J., Rabchevsky, A.G., Chris-lakos, S., Clair, D.K., Mattson, M.P., Scheff, S.W, 1999. Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.J Neurosci,19:6248–3260. DOI: 10.1523/JNEUROSCI.19-15-06248.1999
15. Suzumura, A., Ito, A., Yoshikowa, M., Sawada, M, 1999. Ibudilast suppresses TNF alpha production by glial cells functioning mainly as type III phosphodiesterast inhibition in the CNS.Brain Res,837:203–212. DOI: 10.1016/S0006-8993(99)01666-2